Peter Thornton

Title: Peter Thornton: Innovator in Antibody Research

Introduction

Peter Thornton is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents, his work focuses on innovative solutions that have the potential to impact medical research and treatment.

Latest Patents

Thornton's latest patents include "Nucleic acids encoding anti-PAR2 antibodies and uses thereof." This patent provides antibodies and antigen-binding fragments capable of binding to PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using these antibodies and antigen-binding fragments. Another significant patent is "Anti-PAR2 antibodies and uses thereof," which shares similar features and applications as the previous patent, emphasizing the importance of these antibodies in therapeutic contexts.

Career Highlights

Peter Thornton is currently associated with Medimmune Limited, where he continues to advance his research in antibody development. His work has been instrumental in exploring new avenues for therapeutic interventions, particularly in the realm of immunology.

Collaborations

Thornton has collaborated with notable colleagues, including Claire Louise Dobson and Richard Williams, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Peter Thornton's contributions to antibody research exemplify the spirit of innovation in biotechnology. His patents reflect a commitment to advancing medical science and improving therapeutic options for patients.